Bone and Mineral Metabolism in Patients with Primary Aldosteronism

Table 4

Bone mineral density (BMD) evaluated by dual-energy X-ray absorptiometry (DXA) in all subjects enrolled.

Patient	𝑇-score L1–L4	BMD L1–L4 (g/cm^2)	𝑇-score FN	BMD FN (g/cm^2)
PA (n.73)	−0.28±1.3^∗	1.01±0.17^∗	−0.67±1.1^∗	0.84±0.16
EH (n.73)	0.03±0.6	1.11±0.17	−0.29±0.7	0.84±0.12
HS (n.40)	0.027±0.8	1±0.09	−0.30±0.6	0.81±0.08
𝑃	0.06* versus EH-HS	0.06* versus EH-HS	0.06* versus EH-HS	ns
APA (n.35)	−0.30±1.3	1±0.18	−0.7±1.05	0.82±0.14
IHA (n.38)	−0.25±1.4	1.02±0.17	−0.63±1.3	0.85±0.19
𝑃	ns	ns	ns	ns

PA: primary aldosteronism; EH: essential arterial hypertension, HS: healthy subjects; APA: aldosterone-producing adrenal adenoma; IHA: idiopathic bilateral hyperplasia; L1–L4: lumbar spine side; FN: femoral neck side.